Skip to main content
. Author manuscript; available in PMC: 2020 May 7.
Published in final edited form as: Cancer Chemother Pharmacol. 2018 May 25;82(2):211–219. doi: 10.1007/s00280-018-3599-3

Table 2:

Adverse events of grade (Gr) 3 or greater that were possibly related to X-82.

Adverse event Number of pts high dose cohort Number of pts low dose cohort
Gr 3 Hypertension 1 -
Gr 3 Low WBC 1 -
Gr 3 Infection 1 1
Gr 3 Anemia 1 -
Gr 3 Hyponatremia 1 1
Gr 3 Hypoalbumenia 1 -
Gr 3 Thrombosis 1 -
Gr 3 Rectal Hemorrhage - 1